This document discusses neonatal seizures. It begins by defining neonatal seizures as paroxysmal behavior caused by hyper-synchronous discharge of neurons, which is a medical emergency signaling potential brain damage. It then classifies seizures as subtle, tonic, clonic, or myoclonic and lists common causes like hypoxic-ischemic encephalopathy and infections. Diagnosis involves history, examination, and investigations like blood tests, imaging, and EEG. Management includes treating underlying causes like hypoglycemia and hypocalcemia. Anti-epileptic drugs should be considered for persisting or repeated seizures. Nursing care involves emergency response, observation, and psychosocial support of families.
Definition
A seizure is defined clinically as a paroxysmal alteration in neurologic function (i.e., behavioral, motor, or autonomic function).
Includes phenomena that are associated temporally with seizure activity identifiable on an EEG and, therefore, are clearly epileptic
Also includes paroxysmal clinical phenomena that are not consistently associated temporally with EEG seizure activity
Pathophysiology
Immature brain has many differences from the mature brain that render it more excitable and more likely to develop seizures.
Delay in Na+ , K+ -adenosine triphosphatase maturation and increased NMDA and AMPA receptor density.
Delay in the development of inhibitory GABAergic transmission
GABA in the immature brain has an excitatory function
Causes of Neonatal seizures
The majority of neonatal seizures occur in the context of acute neurologic disorders.
Thus most neonatal seizures may be considered acute symptomatic seizures, which have been defined as seizures occurring at the time of a systemic insult or in close temporal association (often 1 week) with a documented brain insult.
The current IL AE classifies seizure causes as genetic, structural/metabolic, and unknown.
Within that classification scheme, the majority of neonatal seizures are structural/ metabolic in etiology.
The most common underlying etiologies are HIE, stroke, intracranial hemorrhage, intracranial infections, and cerebral dysgenesis.
Less common but important etiologies include
Inborn errors of metabolism and
Neonatal epileptic syndromes, such as benign familial neonatal epilepsy, benign nonfamilial neonatal seizures, early myoclonic epilepsy, early infantile epileptic encephalopathy, and malignant migrating partial seizures of infancy
Types of Neonatal Seizures
Four essential clinically evident seizure types can be recognized: subtle, clonic, tonic, and myoclonic
Subtle seizures do not have a clear position in the most recent ILAES classification report, but they are very common in newborns
A critical fifth seizure type to consider in newborns is a seizure with no observable clinical correlate, which have been referred to as EEG-only seizures
An important initial distinction in classifying a seizure is whether it has a generalized or focal mechanism of onset
Subtle Seizures
Transient eye deviations, nystagmus, blinking, mouthing,
Abnormal extremity movements (rowing, swimming, bicycling, pedalling, and Stepping),
Fluctuations in heart rate, hypertension episodes, and apnea.
More commonly in premature
Clonic Seizures
Focal:
Involve face upper + /- lower extremities on
one site “axial structures (neck / trunk)
Usually associated with neuropathology (i.e. Cerebral infarction and intra cerebral haemorrhage)
Multi focal:
Involve several body parts and often
migrate in a non-jacksonian (random) manner may also involve the face.
Consider the neonatal equivalent of generalized tonic – clonic seizures.
Definition
A seizure is defined clinically as a paroxysmal alteration in neurologic function (i.e., behavioral, motor, or autonomic function).
Includes phenomena that are associated temporally with seizure activity identifiable on an EEG and, therefore, are clearly epileptic
Also includes paroxysmal clinical phenomena that are not consistently associated temporally with EEG seizure activity
Pathophysiology
Immature brain has many differences from the mature brain that render it more excitable and more likely to develop seizures.
Delay in Na+ , K+ -adenosine triphosphatase maturation and increased NMDA and AMPA receptor density.
Delay in the development of inhibitory GABAergic transmission
GABA in the immature brain has an excitatory function
Causes of Neonatal seizures
The majority of neonatal seizures occur in the context of acute neurologic disorders.
Thus most neonatal seizures may be considered acute symptomatic seizures, which have been defined as seizures occurring at the time of a systemic insult or in close temporal association (often 1 week) with a documented brain insult.
The current IL AE classifies seizure causes as genetic, structural/metabolic, and unknown.
Within that classification scheme, the majority of neonatal seizures are structural/ metabolic in etiology.
The most common underlying etiologies are HIE, stroke, intracranial hemorrhage, intracranial infections, and cerebral dysgenesis.
Less common but important etiologies include
Inborn errors of metabolism and
Neonatal epileptic syndromes, such as benign familial neonatal epilepsy, benign nonfamilial neonatal seizures, early myoclonic epilepsy, early infantile epileptic encephalopathy, and malignant migrating partial seizures of infancy
Types of Neonatal Seizures
Four essential clinically evident seizure types can be recognized: subtle, clonic, tonic, and myoclonic
Subtle seizures do not have a clear position in the most recent ILAES classification report, but they are very common in newborns
A critical fifth seizure type to consider in newborns is a seizure with no observable clinical correlate, which have been referred to as EEG-only seizures
An important initial distinction in classifying a seizure is whether it has a generalized or focal mechanism of onset
Subtle Seizures
Transient eye deviations, nystagmus, blinking, mouthing,
Abnormal extremity movements (rowing, swimming, bicycling, pedalling, and Stepping),
Fluctuations in heart rate, hypertension episodes, and apnea.
More commonly in premature
Clonic Seizures
Focal:
Involve face upper + /- lower extremities on
one site “axial structures (neck / trunk)
Usually associated with neuropathology (i.e. Cerebral infarction and intra cerebral haemorrhage)
Multi focal:
Involve several body parts and often
migrate in a non-jacksonian (random) manner may also involve the face.
Consider the neonatal equivalent of generalized tonic – clonic seizures.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
2. Objectives
To Understand about Neonatal seizures.
Enumerates causes of Neonatal seizures.
Explain types of Neonatal seizures.
Describe diagnosis procedure of Neonatal
seizures
Explain Treatment and Nursing Management of
Neonatal seizures.
3. outline
Introduction
Definition
Classification of seizure
causes of neonatal seizure
Diagnosis
Investigation
Management for the neonatal seizure
3
4. Introduction
Neonatal seizures are usually the clinical
manifestation of a serious underlying disease.
Seizures constitute a medical emergency
because they signal a disease process that
may produce irreversible brain damage
5. Definition
A seizure is a paroxysmal behaviour caused
by hyper-synchronous discharge of a group
of neurons.
Neonatal seizures are the most common
overt manifestation of neurological
dysfunction in the newborn.
7. Subtle
Specially seen in preterm and term.
In this clinical manifestation are mild &
frequently missed.
Usually mild paroxysmal alterations in motor,
behavior or autonomic function that are not
clearly clonic, tonic or myoclonic.
Commonest type constitute 50% of all
seizures.
8. Tonic
Primarily preterm.
Characterized by flexion or extension of axial
or appendicular muscle groups.
May be focal or generalized.
Decerebrate - tonic extension of all limbs
Decorticate - flexion of upper limbs &
extension of lower limbs.
No ECG change.
8
9. Clonic
Primarily term.
Rhythmic movement of muscle
groups.
1-3 jerk per second.
Associated with EEG changes
9
10. MyoClonic
Single or multiple lightning fast
jerks of the upper or lower limbs
and are usually distinguished from
clonic movements because of more
rapid speed of myoclonic jerks,
absence of slow return and
predilection for flexer muscle
group.
10
13. Assessment
1) History
• Seizure history
• Antenatal history
• Perinatal history
• Feeding history
• Family history
2) Examination
Vitals signs , general examination, CNS
examination , systemic examination
15. Screening for congenital infections
TORCH screen and VDRL
Metabolic screening
Blood and urine ketones,
- Urine reducing substances
- Blood ammonia, anion gap
- Urine and plasma aminoacidogram
- Serum and CSF lactate/ pyruvate ratio
Electro-encephalogram (EEG)
16. Initial medical management:
Thermoneutral environment - Ensure airway,
breathing and circulation
O2 inhalation
IV access & fluid administration
Blood test for sugar and other investigations.
A brief relevant history should be obtained
Quick clinical examination
Hypoglycemia
Check glucose level-
If shows hpoglycemia,
- 2 ml/kg of 10% dextrose should be given as a
bolus injection followed by a continuous infusion
of 6-8 mg/kg/min.
17. Hypocalcemia
After treatment of hypoglycemia give 2ml/kg of 10%
calcium gluconate IV over 10 minutes under strict
cardiac monitoring.
If ionized calcium levels are suggestive of hypocalcemia,
the newborn should receive calcium gluconate at 8
ml/kg/d for 3 days.
If seizures continue despite correction of hypocalcemia,
0.25 ml/kg of 50% magnesium sulfate should be given
intramuscularly (IM).
17
18. Anti-epileptic drug therapy (AED)
Anti-epileptic drug therapy (AED) Anti-epileptic drugs (AED)
should be considered in the presence of even a single clinical
seizure
Anti-epileptic drugs (AED) should be considered in the
presence of even a single clinical seizure
AED should be given if seizures persist even after correction of
hypoglycemia/ hypocalcemia.
18
19. Emergency Care & observation during seizure:-
A nurse should be prepared for first aid measures & should instruct to the family members. This includes:
• - Lie down the child in a flat surface and Loosen tight clothes.
• - Remove dangerous object from the area.
• - Do not force in to the child's mouth.
• - Allow the seizures to run.
• - After the seizures stop turn the child to one side to drain the saliva.
• - Check breathing pattern give CPR if needed .
• - Observe child until fully conscious and Treat any injury if had.
20. Psychosocial care of family members:-
Epilepsy caries a stigma in the society.
Child may feel different from their peers & their parents may not allow their children to have
friendship with them.
Child will become frustrated, epileptic child should be encouraged to do their best in school.
Their seizures should not be used as an excuse to shirk their responsibilities.
21. AIIMS-NICU protocols
2007
Abstract:-
Seizures in the newborn period constitute a medical emergency. Subtle
seizures are the commonest type of seizures occurring in the neonatal
period. Other types include clonic, tonic, and myoclonic seizures.
Myoclonic seizures carry the worst prognosis in terms of long-term
neuro developmental outcome. Hypoxic-ischemic encephalopathy is the
most common cause of neonatal seizures. Multiple etiologies often co-
exist in neonates and hence it is essential to rule out common causes
such as hypoglycemia, hypocalcemia, meningitis before initiating specific
therapy. A comprehensive approach for management of neonatal
seizures has been described.
22. References
National Neonatal Perinatal Database. Report for year National
NeonatologyForum, India. 2002-03.
Volpe JJ. Neonatal Seizures. In Neurology of the newborn. Philadelphia: WB
Saunders,1999; 172-225'
Painter MJ, Scher MS, Stein MD, Armatti S, Wang Z, Gardner JC et al.
Phenobarbitonec ompared with phenytoin for treatment of neonatal seizures.
N Engl J Med 1999:341:485-9
Rennie JM. Neonatal seizures. Eur J Pediatr 1997;156:83-7
Nirupama Laroia. Controversies in diagnosis and management of neonatal
seizures.Indian Pediatr 2000;37:367-72